PALISADE BIO, INC. (PALI)
↓ Download CSV- Sector Manufacturing
- Incorporated DE
- Fiscal year ends Dec 31
In fiscal 2025, PALISADE BIO, INC. reported revenue of $0. The company ran a net loss. It held $134.34M in total assets against $4.96M in total liabilities.
Key ratios (FY2025)
-13.0%
Return on equity
| Metric (FY) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $300.0K | — | — | $13.5K | $15.4K | $260.0K | $260.0K | — |
| Operating Income | -$18.06M | -$14.86M | -$13.07M | -$15.72M | -$41.85M | -$9.30M | -$8.63M | -$8.26M | -$13.31M | -$20.64M |
| Net Income | -$16.78M | -$14.44M | -$12.30M | -$14.26M | -$26.62M | -$10.32M | -$8.35M | -$4.92M | -$15.67M | -$21.07M |
| EPS (Diluted) | $-0.30 | $-10.19 | $-27.01 | $-16.53 | $-169.74 | $-3.72 | — | — | — | — |
| Total Assets | $134.34M | $10.88M | $14.05M | $15.76M | $12.51M | $3.02M | $6.58M | $7.68M | $13.88M | $22.60M |
| Total Liabilities | $4.96M | $3.39M | $2.74M | $3.28M | $5.15M | $10.12M | $1.46M | $1.63M | $5.37M | $11.27M |
| Shareholders' Equity | $129.38M | $7.49M | $11.31M | $12.48M | $7.37M | -$16.60M | -$8.33M | $6.05M | $8.52M | $11.33M |
| Cash & Equivalents | $133.38M | $9.82M | $12.43M | $12.38M | $10.49M | $713.0K | $5.11M | $5.79M | $6.67M | $15.19M |
| Operating Cash Flow | -$10.85M | -$12.19M | -$11.13M | -$13.36M | -$14.77M | -$4.77M | -$7.26M | -$7.69M | -$13.42M | -$15.62M |
| Capital Expenditures | — | $0 | $4.0K | $10.0K | $0 | $6.0K | — | $1.7K | $11.4K | $98.1K |
| Shares Outstanding | 159.44M | 2.77M | 618.1K | 2.94M | 284.8K | 2.77M | 3.87M | 910.3K | 15.16M | 11.03M |